Research Progress on the Regulation of Pulmonary Hypertension by the NOTCH3 Signaling Pathway

Area of Science:

• Cardiovascular Biology
• Molecular Signaling
• Pulmonary Medicine

Background:

• Pulmonary hypertension (PH) presents significant challenges due to high mortality, early onset, and limited treatment options.
• The NOTCH3 signaling pathway, known for its context-dependent oncogenic or tumor-suppressive roles, is implicated in cardiovascular disorders.
• Emerging evidence links NOTCH3 pathway dysregulation to the pathophysiology and inflammation underlying PH.

Purpose of the Study:

• To review the origins and fundamental aspects of the NOTCH signaling pathway.
• To summarize the multifaceted involvement of NOTCH3 signaling in PH pathogenesis, focusing on vascular remodeling and biological functions.
• To provide a theoretical basis for advancing PH research and developing targeted pharmaceutical interventions.

Main Methods:

• Literature review focusing on NOTCH signaling pathways.
• Analysis of existing research on NOTCH3's role in cardiovascular diseases, particularly PH.
• Synthesis of findings related to vascular remodeling mechanisms and biological functions in PH.

Main Results:

• The NOTCH3 signaling pathway is closely associated with pulmonary hypertension.
• Dysregulation of NOTCH3 contributes to vascular remodeling processes in PH.
• Current understanding of NOTCH3's precise mechanisms and therapeutic targeting in PH remains incomplete.

Conclusions:

• NOTCH3 signaling pathway dysregulation is a key factor in pulmonary hypertension development.
• Further research into NOTCH3's mechanisms is essential for novel therapeutic strategies.
• Targeting the NOTCH3 pathway holds promise for future PH drug development.